Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $52.7600 (-0.89%) ($51.3700 - $52.7600) on Thu. Nov. 17, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.29% (three month average) | RSI | 67 | Latest Price | $52.7600(-0.89%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.2% a day on average for past five trading days. | Weekly Trend | HALO advances 6.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(37%) IFRA(32%) IWM(31%) IWO(31%) IWN(30%) | Factors Impacting HALO price | HALO will decline at least -1.145% in a week (0% probabilities). VIXM(-9%) VXX(-6%) XBI(-4%) XME(-2%) TBT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.145% (StdDev 2.29%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $53.56(-1.49%) | 10 Day Moving Average | $51.11(3.23%) | 20 Day Moving Average | $49.24(7.15%) | To recent high | -2.4% | To recent low | 37% | Market Cap | $7.211b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |